Karnataka Government Offers Free Treatment for Monkeypox

Click to start listening
Karnataka Government Offers Free Treatment for Monkeypox

Synopsis

The Karnataka government has announced free treatment for all monkeypox patients, expanding access beyond BPL cardholders. This initiative is aimed at controlling the disease in the Malenadu region, with plans for a KFD vaccine expected by 2026.

Key Takeaways

  • Karnataka government provides free treatment for monkeypox.
  • Initiative now includes Above Poverty Line families.
  • KFD vaccine trials are progressing.
  • Immediate treatment is critical to prevent severe outcomes.
  • Government is focused on improving public health.

Bengaluru, Feb 15 (NationPress) The Karnataka government has announced that all individuals impacted by monkeypox will receive free treatment.

Previously, this free treatment was limited to those holding Below Poverty Line (BPL) cards.

Monkeypox, also referred to as Kyasanur Forest Disease (KFD), is a significant health concern.

The State Health Minister Dinesh Gundu Rao remarked: "Our government is dedicated to combating KFD, which is increasingly affecting the Malenadu (hilly) region. Treatment for those diagnosed with the illness is being provided at no cost, and this advantage has now been broadened to Above Poverty Line (APL) families as well."

"Affected members of APL families in the state will receive complimentary treatment at hospitals registered under the Suvarna Arogya Suraksha Trust. This initiative will aid numerous families," he added.

"Our government has taken a significant step against monkey fever and has consulted with the Indian Council of Medical Research (ICMR). Following clinical trials, the KFD vaccine is anticipated to be available by 2026. Our government is unwavering in its commitment to protect the health of our state’s citizens," he emphasized.

The districts neighboring the Western Ghats are heavily impacted by this illness.

According to statistics, since 2003, over 59 individuals have lost their lives due to this disease.

"Patients require immediate treatment; otherwise, they face the risk of multiple organ failure and death. Nevertheless, if treated early, the disease is manageable. This decision is aimed at assisting the lower middle and middle classes," Minister Rao stated.

Earlier, Karnataka Health Minister Dinesh Gundu Rao met with the Director-General of the Indian Council of Medical Research (ICMR) Rajiv Bahl in New Delhi to discuss the KFD vaccine.

Minister Rao indicated that human trials for the vaccine are slated for April 2025.

He mentioned that the initial phase of trials for the KFD vaccine has yielded promising outcomes, and the second phase is about to commence. Human trials are planned for April 2025, with the vaccine expected to be accessible for public use by 2026.

During the meeting, Minister Gundu Rao highlighted the crucial role of ICMR's assistance in expediting this process.